Camber Capital Management LP - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.

Quarter-by-quarter ownership
Camber Capital Management LP ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$12,565,000
-72.4%
500,000
-66.7%
0.38%
-80.5%
Q2 2022$45,585,000
-7.2%
1,500,0000.0%1.98%
+11.2%
Q1 2022$49,140,000
-28.7%
1,500,000
+119.0%
1.78%
-16.2%
Q3 2021$68,918,000
+4.7%
685,000
+47.3%
2.12%
-4.3%
Q2 2021$65,811,000
+65.0%
465,000
+16.2%
2.22%
+62.1%
Q1 2021$39,880,000400,0001.37%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders